Uncategorized
Portal portfolio company, Moonlight Therapeutics launches its first-in-human Phase I clinical trial
A significant milestone for our Atlanta-based portfolio company, Moonlight Therapeutics as the company launches its first-in-human Phase I clinical trial evaluating MOON101 for peanut allergy.
Get in touch
Chicago | Providence | New Brunswick | Houston | Dublin
©2026 Portal Innovations, LLC
Sign up for our monthly newsletter
Stay up-to-date on the latest VC, biotech, and med tech news in Chicago and across the U.S. Sign up with your email address below to get our monthly newsletter delivered to your inbox!